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E-mail address: jhenriquez@udec.cl (J.P. HenríquezIn addition to its role as a strong antioxidant, vitamin C regulates the differentiation of several cell
lineages. In vertebrate skeletal muscle, the vitamin C transporter SVCT2 is preferentially expressed
in slow muscle ﬁbers. To gain insights into the possible involvement of intracellular vitamin C on
early myogenesis, we investigated the regulation of SVCT2 expression in cultures of chick fetal myo-
blasts. SVCT2 expression increases in cultures of both, slow and fast muscle-derived myoblasts, as
they fuse to formmainly fast myotubes. Interestingly, we found that SVCT2 could be positively mod-
ulated by potassium-induced depolarization of myotubes. These ﬁndings suggest that SVCT2-medi-
ated uptake of vitamin C could play diverse roles on skeletal muscle development and physiology.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The formation of skeletal muscle during development involves a
series of sequential events, including the commitment of somite-
derived precursor cells to mononucleated myoblasts, and their
subsequent fusion into multinucleated myotubes [1]. Mature
skeletal muscles consist of variable proportions of fast and slow
myoﬁbers which, ultimately, account for their contractile activity
[2]. Fiber types can be classiﬁed according to various parameters,
such as the expression of type-speciﬁc protein isoforms and meta-
bolic properties. Indeed, whereas most fast ﬁbers are glycolytic,
slow myoﬁbers rely on oxidative metabolism for a permanent sup-
ply of ATP [2].
Both mammalian and avian model systems have been em-
ployed to identify the intrinsic properties and extrinsic factors that
determine the characteristics of mature ﬁbers [2,3]. Whereas mur-
ine myoblasts seem preprogrammed to a particular phenotype [4],
the deﬁnition of skeletal muscle ﬁber types in the chick relies onchemical Societies. Published by E
orter 2; PM, pectoralis major;
c reticulum calcium ATPase;
dorsi; NFAT, nuclear factor of
B cells
evelopmental Neurobiology,
nces, Universidad de Concep-
45975.
).the patterning of muscle precursors, but also signiﬁcantly on their
innervation [5].
Vitamin C is the most important water-soluble antioxidant vita-
min in the plasma and, as such, it has been characterized as one of
the main non-enzymatic antioxidative systems in various tissues
[6,7]. To accomplish intracellular functions, vitamin C must be efﬁ-
ciently incorporated into cells. Thus, whereas oxidized vitamin C,
dehydroascorbic acid, is taken up by facilitative hexose transport-
ers [8,9], two isoforms of high afﬁnity sodium-dependent vitamin
C co-transporters (SVCT1 and 2) mediate the uptake of ascorbic
acid, the reduced form of vitamin C [10,11].
In addition to its role as a potent antioxidant, cumulative evi-
dence supports that vitamin C positively regulates the differentia-
tion of diverse cell lineages, such as osteoblasts, keratinocytes, and
cells of the nervous system [12–15]. Interestingly, these effects of
vitamin C are accompanied by dynamic expression patterns of
their SVCT transporters [15–18], thus supporting the notion that
transporter-mediated uptake of vitamin C is involved in cell
differentiation.
We have recently conducted the ﬁrst detailed characterization
of sodium-vitamin C co-transporter 2 (SVCT2) expression in skele-
tal muscles [19]. Our data showed that SVCT2 is preferentially ex-
pressed in slow skeletal myoﬁbers in both developing chicks and
adult mammalian species, including human [19]. These ﬁndings
suggest that the uptake of vitamin C may help to counteract oxida-
tion in mature slow muscle ﬁbers. However, a possible role forlsevier B.V. All rights reserved.
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dressed. Here, we have analyzed the expression of SVCT2, and its
regulation by depolarization, in cultures of chick fetal myoblasts
obtained from fast and slow muscles. Together with previous evi-
dence, our data suggest that skeletal muscle development and
physiology could be regulated by intracellular vitamin C.Fig. 1. SVCT2 is expressed in chick myotubes. (a) Total RNAs from PM andMA day 5
myotubes were subjected to RT-PCR analyses to detect chick SVCT2 (upper gel), and
the housekeeping control b-actin (lower gel). RNA from HH42 chick brain and
reverse transcriptase negative reactions (RT-) were used as positive and negative
controls, respectively. Molecular size standard (in bp) are shown on the left. Arrows
on the right indicate the molecular size of the observed bands. (b) Total proteins
from day 5 PM and MAmyotubes were analyzed by Western blot using a polyclonal
anti rat SVCT2 antibody. Proteins samples from HH38 chick brain were used as
positive control, whereas pre-incubation of anti SVCT2 with the inhibitory peptide
(IP) was used as negative control. Mass standard markers (in kDa) are shown on the
left. Arrows on the right show the mass of the observed bands. (c) PM and MA
myoblasts were differentiated for 5 days, ﬁxed, and subsequently stained with an
anti SVCT2 antibody (green). ToPro (blue) was used to counterstain nuclei. Bar,
50 lm.2. Materials and methods
2.1. Animals
Fertilized chick eggs were incubated at 37.5 C in a circulated
air incubator. Chick embryos were staged according to Hamburger
and Hamilton (HH stages) [20]. Experiments were conducted fol-
lowing the guidelines outlined in the Biosafety and Bioethics Man-
ual of the National Commission of Scientiﬁc and Technological
Research (CONICYT, Chilean Government). The Ethics Committee
of University of Concepcion (Concepcion, Chile) approved all
experimental procedures carried out during this study.
2.2. Cell cultures
Myoblasts were isolated from embryonic HH38 White Leghorn
chick fast pectoralis major (PM) and slow medial adductor (MA)
muscle tissue, as previously described [21]. The tissue was
mechanically disrupted and then treated with 0.25% trypsin (Hy-
Clone, South Logan, UT, USA) for 15 min at 37 C under mild agita-
tion. Cells were suspended in growth medium (DMEM high glucose
(Hyclone), 20% fetal bovine serum (Hyclone), 2% chick embryo ex-
tract and antibiotics) with repeated pipetting. The cell suspension
was ﬁltered through a triple nylon cloth ﬁlter and centrifuged
1500g for 5 min. Cells were plated at a density of 50,000 cells
per cm2 of 0.5% gelatine-coated culture dishes in complete med-
ium. To induce differentiation, growth medium was replaced with
differentiation medium (DMEM high glucose, 10% horse serum
plus 2.5% fetal bovine serum, 2% chick embryo extract and antibi-
otics) at day 2.
2.3. Reverse transcription – polymerase chain reaction (RT-PCR)
Total RNA from PM and MA myoblasts cultures was reverse
transcribed as previously described [19]. For ampliﬁcation, a cDNA
aliquot in a volume of 12.5 ll containing (in mM) 20 Tris buffer pH
8.4, 50 KCl, 1.6 MgCl2, 0.4 dNTPs, plus 0.04U Taq polymerase (Fer-
mentas, ON, Canada) was incubated 95 C for 5 min, 95 C for 30 s,
58 C for 30 s and 72 C for 30 s for 32 cycles. Primers were de-
signed based on the chick SVCT2 sequence, as described [19]. PCR
products were separated by 1.2% agarose gel electrophoresis and
visualized following ethidium bromide staining.
2.4. Western blot
Total proteins were obtained at different culture days by scrap-
ing culture dishes in a 0.3 M sucrose solution containing a protease
inhibitor cocktail (80 lM aprotinin, 1.5 mM pepstatin A, 2 mM leu-
peptin, 104 mM AEBSF, 4 mM Bestatin, 1.4 mM E-64) (Sigma, St.
Louis, MO, USA), and extensive passing myotube extracts through
a 1 ml syringe. Supernatants containing the total protein extracts
were obtained after centrifuging at 6000g for 10 min at 4 C. Pro-
teins from fast and slow muscles were extracted as described [19].
For immunoblotting, 100 lg (muscle tissue) or 30 lg (cultured
myotubes) were loaded in each lane and fractionated by SDS–
PAGE, transferred to nitrocellulose membranes, and probed against
goat anti rat SVCT2 1/200 (G-19, Santa Cruz Biotechnology, Santa
Cruz, CA, USA), mouse anti chick fast C-protein [22] 1/200, mouseanti chick slow sarco/endoplasmic reticulum calcium ATPase (SER-
CA) [23] 1/200, or goat anti human b-actin 1/5000 (Santa Cruz Bio-
technology) antibodies overnight at 4 C. Antibodies against chick
muscle proteins were obtained from the Developmental Studies
Hybridoma Bank at The University of Iowa, IA, USA. Peroxidase-
conjugated secondary antibodies 1/2000 (Jackson Immuno
Research, West Grove, PA, USA) were incubated for 2 h at RT. Reac-
tions were developed with enhanced chemiluminescence accord-
ing to the ECL Western blotting analysis system (Perkin–Elmer,
Waltham, MA, USA).
2.5. Immunochemistry
Chick embryo forelimbs were cryosectioned and immuno-
stained with anti SVCT2 along with anti chick fast SERCA [23], as
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coated 13-mm diameter glass coverslips, differentiated for 5 days,
and ﬁxed with cold methanol for 5 min. Cells were incubated with
anti SVCT2 1/100 antibody diluted in Tris phosphate buffer con-
taining 1% BSA, for 12–15 h at 4 C. The corresponding alexa488-
conjugated secondary immunoglobulin (Invitrogen, Carlsbad, CA,
USA) was incubated for 2 h at RT, and the slides were subsequently
mounted with aqueous medium for ﬂuorescence (Sigma). Images
were acquired with a laser confocal Nikon D-Eclipse C1 micro-
scope. Control experiments, performed in the absence of primary
antibodies and by co-incubation with the inhibitory peptide (Santa
Cruz Biotechnology), gave negative results (data not shown).
Nuclei were stained by co-incubation with ToPRO-3 (Invitrogen),
along with the secondary immunoglobulin.
2.6. Depolarization
Day 3 chick myotubes were incubated with Krebs–Ringer
medium containing (in mM) 4.7 KCl, 20 HEPES-Tris, pH 7.4, 118
NaCl, 3 CaCl2, 1.2 MgCl2, and 10 glucose, under resting conditions
for 30 min. Depolarization was induced by incubation in a med-
ium containing 84 mM KCl, whereas the sodium concentration
was decreased proportionally to maintain the osmolarity of the
solution. After a 5 min depolarization period, cells were re-incu-
bated under resting conditions for the indicated times. Both con-
trol and experimental cells were subjected to semiquantitative
RT-PCR and Western blots analyses, as described [24,25]. DataFig. 2. SVCT2 is up-regulated during differentiation of PM and MA myoblasts. (a and b) T
myoblast cultures for RT-PCR analyses aimed to amplify chick SVCT2 and b-actin transcr
bands. (c and d) Total proteins from PM (c) and MA (d) myotubes were extracted at the i
antibody. b-actin levels are shown as loading control. Arrows on the right of each repres
representative gel show the average ± SEM of the SVCT2:b-actin band intensity ratios of
t-test.are expressed as the ratio of SVCT2:b-actin band intensities in
depolarized myotubes normalized to control, unstimulated cul-
tures (not shown).3. Results and discussion
3.1. SVCT2 expression is up-regulated during in vitro differentiation of
fetal myoblasts
Growing evidence points to a relevant role for intracellularly
transported vitamin C as a positive modulator of cell differentia-
tion. For instance, differentiation of human-derived THP-1
monocytes [26], and two keratinocyte cell lines [15], occurs con-
comitantly with SVCT2 up-regulation. On the other hand, the in-
creased expression of SVCT2, as well as ascorbate treatment, of
mouse MC3T3-E1 preosteoblast cells leads to up-regulation of
osteoblast-related proteins and to the mineralization of a collage-
nous extracellular matrix [13,18]. In addition, SVCT2 is expressed
in a variety of cells of the nervous system, such as neurons
[11,16,27], and different glial cells [17,28]. Consistently, ascorbic
acid promotes the differentiation of precursor cells isolated from
rat embryonic brain cortex [14], mesencephalic precursor cells
[29], and peripheric glial Schwann cells [12].
As a ﬁrst hint to analyze SVCT2 expression in early myogenesis,
we cultured chick fast PM- and slow MA-derived myoblasts and
differentiated them for ﬁve days. We conducted RT-PCR analysesotal RNA was obtained at the indicated times of differentiation of PM (a) and MA (b)
ipts. Arrows on the right of each panel indicate the molecular size of the observed
ndicated times of differentiation and analyzed by Western blot using an anti SVCT2
entative gel indicate the Mr of the observed bands. (a–d) Plots at the bottom of each
three experiments performed by triplicate. ⁄P < 0.05, ⁄⁄P < 0.01, ⁄⁄⁄P < 0.001, paired
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SVCT2 and a 282 bp fragment of chick b-actin mRNA, used here
as housekeeping control (Fig. 1a). Negative control experiments
performed in the absence of reverse transcriptase did not show
PCR products. Total RNA from HH42 chick brain was used as posi-
tive control. As shown in Fig. 1a, a speciﬁc SVCT2 fragment was
ampliﬁed from PM and MA myotubes. To analyze SVCT2 expres-
sion at the protein level, total myotube proteins were subjected
to Western blot using an antibody raised against a rat SVCT2 poly-
peptide (Fig. 1b). Positive control experiments using chick brain
extracts from stage HH38 embryos showed a single band of
65,000 Dalton. A similar immunoreactive band was detected in to-
tal protein extracts from PM and MA myotubes (Fig. 1b). As a fur-
ther support of these ﬁndings, the expression of SVCT2 was
addressed by immunocytochemistry in day 5 myotube cultures,
using the same antibody (Fig. 1c). Together with our RT-PCR and
Western blot experiments, these immunodetection analyses show
that chick multinucleated myotubes do express SVCT2.
We next analyzed if SVCT2 expression is regulated during early
myogenesis. First, total RNA samples from day 2 to day 5 myoblasts
cultures were subjected to RT-PCR analyses. As shown in Fig. 2,
SVCT2 transcript is gradually increased as myogenesis proceeds.
Quantiﬁcation of the relative intensity of SVCT2 PCR product re-
veals that, as compared to myoblasts cultured for 2 days, differen-
tiated PM and MA myotubes up-regulate SVCT2 expression by
about ﬁve and sixfold, respectively (Fig. 2a and b). Consistent with
the expression proﬁle of its transcript, the SVCT2 protein was
barely detectable at early stages of myogenesis, and subsequently
increased with the course of differentiation. Quantiﬁcation of band
intensity ratios shows that PM and MA myotubes signiﬁcantly in-
duce SVCT2 expression by about ﬁve and sixfold, respectively
(Fig. 2c and d).
Up-regulation of SVCT2 during the fusion of chick fast- and
slow-muscle derived myoblasts suggests that an increased uptake
of vitamin C could positively modulate early steps of myogenesis.Fig. 3. Dynamic phenotypic proﬁle of differentiating PM and MA myoblasts. Total
protein extracts from HH39 chick embryo skeletal muscles were subjected to
Western blot analyses with ﬁber-type speciﬁc antibodies. (a) Extracts from the slow
muscles ALD and MA, as well as from the fast muscles PLD and PM, were probed
against anti slow SERCA and anti fast C-protein antibodies. (b) Myoblasts obtained
from HH39 PM and MA muscles were differentiated for 5 days. Protein extracts
obtained at various differentiation days (d1–d5) were immunoblotted against slow
SERCA and fast C-protein. An anti b-actin antibody was used as loading control (a
and b). Arrows indicate the Mr of the detected bands.According to this notion, it has been shown that a stable form of
reduced vitamin C, L-ascorbic acid-2 phosphate, promotes the dif-
ferentiation of rat-derived L6 myoblasts, as evidenced by their in-
creased fusion into myotubes [30]. However, in contrast to our
ﬁndings, SVCT2 mRNA and function is down-regulated throughout
in vitro myogenesis of L6 cells [31]. Even though murine and avian
myogenesis may differ in some aspects [3], an attractive interpre-
tation of these seemingly contradictory results could be based on
the myoblasts employed in the different studies. It is well estab-
lished that three populations of myoblasts – called embryonic, fetal
and adult – predominate at different stages of muscle development
[3,4,32]. L6 cells correspond to reliable models of adult myoblasts,
those responsible of muscle growth and regeneration, as they were
isolated from newborn rats [33]. In turn, the fetal myoblasts used
in our studies were isolated from chick HH38 embryos, a develop-
mental stage coinciding with secondary myogenesis, the process
that generates the vast majority of skeletal muscle ﬁbers [34].
Remarkably, vitamin C levels peak during secondary myogenesis
in the chick, and strongly decay towards perinatal stages of devel-
opment, when adult myoblasts predominate [35]. Therefore, even
though further research has to be made to clarify this issue, it is
possible that embryonic, fetal and adult myoblasts may differ in
the mechanisms by which they use vitamin C to modulate
myogenesis.
3.2. Potassium-induced membrane depolarization up-regulates SVCT2
in fast myotubes
Regardless of the phenotype of the prospective muscle they
come from, chick PM and MA fetal myoblasts give rise to fast myo-
tubes in vitro [5]. To determine the phenotypic proﬁle of differen-
tiating PM and MAmyotubes, we performedWestern blot analyses
using monoclonal antibodies raised against slow SERCA and fast C-
protein. We ﬁrst ensured that these antibodies work as reliable
markers of mutually exclusive populations of myotubes by per-
forming immunoblot experiments of HH39 chick embryonic slow
and fast skeletal muscles (Fig. 3a). Our results show that the anti
slow SERCA antibody recognizes a unique 110 kDa band only in
protein samples from the slow-twitch muscles anterior latissimus
dorsi (ALD) and MA, but not in the fast muscles posterior latissimusFig. 4. SVCT2 is not expressed in chick fast secondary myoﬁbers in vivo. Transversal
forelimb cryosections from chick HH38 (left panels) and HH42 (right panels)
embryos were double stained with a goat anti SVCT2 (green), together with a
mouse anti fast SERCA (red) antibody. Alexa488-conjugated anti goat and alexa546-
conjugated anti mouse immunoglobulins were used as secondary antibodies.
Magniﬁed images are shown in the lower panels. Bars, 20 lm.
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tected a 140 kDa band only in PLD and PM, but not in ALD or MA
(Fig. 3a). In myotube cultures, our immunodetection studies show
that undifferentiated fetal myoblasts (day 1) do not express detect-
able amounts of SERCA or sarcomeric C-protein (Fig. 3b). Consis-
tent with their fast and slow origin, PM myotubes differentiated
for 3 days express only the fast marker, whereas MA myotubes ex-
press the slow-speciﬁc protein. However, signiﬁcant amounts of
the fast C-protein were also detected in day 3 MA myotubes. After
5 days of differentiation both, PM and MA cultures, mainly express
the fast phenotype marker (Fig. 3b). Together with our previous
data, these results suggest that in vitro, the increasing SVCT2
expression during early myogenesis is accompanied by the acqui-
sition of fast phenotype, both events likely being independent of
the phenotypic identity of the isolated myoblasts.
In the developing muscle, fetal myoblasts differentiate into sec-
ondary myoﬁbers, which are initially all fast [34]. To analyze
SVCT2 expression in secondary muscle ﬁbers, we performed dou-
ble immunohistochemical staining in forelimb cryosections ob-
tained from developing chick embryos. In these studies, we used
anti SVCT2 along with anti chick fast SERCA antibodies [19]. At
HH38, small secondary fast ﬁbers are attached, in variable
amounts, to the surface of slow SVCT2-expressing, ring-shaped pri-
mary myoﬁbers (Fig. 4). At HH42 both, slow and fast ﬁbers, haveFig. 5. SVCT2 is up-regulated after potassium-induced membrane depolarization. (a) PM
conditions for the indicated times. Total RNA was isolated and SVCT2 mRNA levels wer
products from SVCT2 and b-actin mRNA ampliﬁcation. (b) Total protein samples were ob
stimulus. SVCT2 levels were analyzed by Western blot using an anti rat SVCT2 antibody
actin. Plots at the bottom of each representative gel show the band intensity ratios of SVCT
quantiﬁcation of three experiments performed by triplicate. ⁄P < 0.05, ⁄⁄P < 0.01, paired
modulated by SVCT-mediated uptake of ascorbic acid (AA). Once myoﬁbers are functiona
metabolism, which subsequently increases oxidation. As oxidation up-regulates SVCT2, t
oxidation.grown and slow primary ﬁbers become surrounded by a halo of de-
tached fast secondary ﬁbers. Immunostaining shows that SVCT2 is
strongly expressed in slow (primary) ﬁbers, whereas recently
formed fast secondary myoﬁbers in vivo do not express detectable
amounts of the transporter (Fig. 4).
Taken these data together, we speculate that our in vitro ﬁve
days cultures represent the early fusion of myoblasts into myotu-
bes, a process that may require intracellular vitamin C. This idea
is supported by the effect of L-ascorbic acid-2 phosphate on L6
myoblasts differentiation, which is mediated by the early induction
of the muscle master gene myogenin [30]. Thus, fetal myoblasts
could up-regulate SVCT2 during early muscle differentiation. This
induction of SVCT2 could, however, be transient; once secondary
myotubes begin to grow and mature by the addition of more fetal
myoblasts, fast-twitch myoﬁbers do not express SVCT2 longer
(Fig. 4), and the transporter becomes mainly expressed in slow-
twitch muscle ﬁbers [19].
Which are the molecular mechanisms involved in the highly
restrictive expression of SVCT2 in oxidative myoﬁbers? Numerous
studies have demonstrated that innervation greatly impacts not
only the establishment of speciﬁc muscle ﬁber types during devel-
opment, and their subsequent maintenance, but also the occur-
rence of ﬁber type transitions [2,36]. In avian and mammalian
species, activity-dependent induction of slow ﬁber proteins ismyotubes were depolarized for 5 min with 84 mM KCl and changed back to resting
e analyzed by semi-quantitative RT-PCR. Top, representative agarose gel of RT-PCR
tained from high potassium-depolarized PM myotubes at the indicated times after
. Top, representative immunoblotting of anti SVCT2 and the loading control anti b-
2:b-actin, normalized to control unstimulated (K-) myotubes, and correspond to the
t-test. (c) We propose a model in which the early fusion of myoblasts could be
lly innervated, the ATP requirements of slow skeletal ﬁbers are fulﬁlled by oxidative
he elevated uptake of ascorbic acid could act as an efﬁcient regulator of intracellular
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dephosphorylation of the nuclear factor of activated T cells (NFAT),
which translocates to the nucleus to activate target genes in coop-
eration with other transcription factors [37,38]. Interestingly, high
potassium depolarization of rat myotubes results in transcriptional
regulation of more than 400 genes, including the up-regulation of
NFAT [25], and of the slow-speciﬁc isoforms of the sarcomeric tro-
ponins I and C [24]. Therefore, as a ﬁrst hint to analyze if innerva-
tion of skeletal muscles could modulate SVCT2 expression, we
challenged chick fast PM myotubes to high (84 mM) KCl depolar-
ization for 5 min, and changed them back to resting conditions.
Samples were collected at different times after potassium stimula-
tion and the expression of SVCT2 and b-actin transcripts was fol-
lowed by a standardized semi-quantitative RT-PCR approach
(Supplementary data Fig. 1). Our results show that myotube depo-
larization resulted in a signiﬁcant up-regulation of SVCT2 mRNA.
Quantiﬁcation of band intensities against control unstimulated
myotubes show a threefold increase in SVCT2 expression 8 hours
after potassium depolarization (Fig. 5a). Accordingly, immunode-
tection experiments showed a ﬁvefold increase of SVCT2 protein
after the depolarizing stimulus, as compared to controls (Fig. 5b).
These experiments suggest that speciﬁc patterns of electrical stim-
ulation could somehow be involved in the preferential expression
of SVCT2 in slow myoﬁbers. In this regard, well-known evidence
demonstrates: (a) that oxidation increases due to muscle activity,
and (b) that oxidation itself stimulates a variety of antioxidant re-
sponses in slowmuscle ﬁbers [39]. Interestingly, it has been shown
that hydrogen peroxide treatment of mouse C2C12 myotubes re-
sults in up-regulation of SVCT2 via the nuclear factor j of activated
B cells (NFjB) [40]. Besides, NFjB expression is increased after
high potassium stimulation of rat myotubes [41]. Therefore, oxida-
tion could somehow mediate the activity-dependent control of
SVCT2 expression in mature slow muscle ﬁbers.
As our data suggest two levels of regulation of SVCT2 expres-
sion, at early and later events of myogenesis, we propose a model
where vitamin C regulates different steps of skeletal muscle devel-
opment (Fig. 5c). First, intracellular vitamin C could be required for
early muscle differentiation, as the fusion of chick fetal fast and
slow-twitch muscle-derived myoblasts into fast myotubes is
accompanied by up-regulation of SVCT2. This notion is strongly
supported by cumulative evidence showing that SVCT2-mediated
uptake of ascorbic acid potentiates the differentiation of several
cell lineages. On the other hand, our immunolocalisation studies
in developing chick muscles show that fast secondary myoﬁbres,
which are differentiated from fast and slow myoblasts in vivo, do
not express SVCT2 longer, suggesting that other mechanisms
should account for SVCT2 expression in mature slow muscle ﬁbres.
We provide novel evidence to show that SVCT2 can be up-regu-
lated by potassium-induced depolarization of fast myotubes. Along
with previous ﬁndings, we propose that functional activity could
trigger oxidation-dependent up-regulation of SVCT2. This mecha-
nism would be particularly relevant in slow myoﬁbers, as they
use oxidative metabolism for energy production. In this regard, it
is relevant to mention that no clear evidence exists to demonstrate
a protective role for vitamin C supplementation against exercise-
induced oxidation [42]. It is then likely that up-regulation of the
SVCT2 transporter could provide skeletal muscles, and perhaps
other tissues, an efﬁcient and sustained adaptive response against
oxidative stress.
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